Pleural effusion epidemiology and demographics: Difference between revisions
Prince Djan (talk | contribs) No edit summary |
Prince Djan (talk | contribs) (→Age) |
||
| Line 18: | Line 18: | ||
===Age=== | ===Age=== | ||
Tuberculous pleural effusion commonly affects 15-44 years group.<ref name="pmid24721286">{{cite journal| author=Ferreiro L, San José E, Valdés L| title=Tuberculous pleural effusion. | journal=Arch Bronconeumol | year= 2014 | volume= 50 | issue= 10 | pages= 435-43 | pmid=24721286 | doi=10.1016/j.arbres.2013.07.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24721286 }} </ref> | |||
===Gender=== | ===Gender=== | ||
===Race=== | ===Race=== | ||
Revision as of 14:26, 14 October 2016
|
Pleural effusion Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleural effusion epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pleural effusion epidemiology and demographics |
|
Risk calculators and risk factors for Pleural effusion epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
In the United States, up to one million patients develop parapneumonic effusions annually, and approximately 100,000 patients undergo pleurodesis for recurrent pleural effusions per year.[1] Pleural effusion is reported to have an incidence of 0.32% in a study among the general population in central Bohemia. Congestive heart failure accounts for nearly 50% of cases, with malignancy, pneumonia and pulmonary emboli as the next three leading causes.[2] However, the distribution of causes is largely dependent on the population studied.
Epidemiology and Demographics
Incidence and prevalence
In the United States, up to one million patients develop parapneumonic effusions annually, and approximately 100,000 patients undergo pleurodesis for recurrent pleural effusions per year.[1] Pleural effusion is reported to have an incidence of 0.32% in a study among the general population in central Bohemia. Congestive heart failure accounts for nearly 50% of cases, with malignancy, pneumonia and pulmonary emboli as the next three leading causes.[2] However, the distribution of causes is largely dependent on the population studied.
The incidence of pleural effusion among ICU patients is estimated to be 22.19 +/- 17%.[3]
Tuberculosis is one of the most frequent causes of pleural effusion. Although the incidence has steadily declined in some coluntries (4.8 cases/100,000 population), the prevalence of tuberculous pleural effusion remains steady with respect to the total number of TB cases (14.3%-19.3%).[4]
Age
Tuberculous pleural effusion commonly affects 15-44 years group.[4]
Gender
Race
Developed countries
=Developing countries
References
- ↑ 1.0 1.1 Light, Richard J. (2007). Pleural diseases. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-6957-4.
- ↑ 2.0 2.1 Marel M, Zrůstová M, Stasný B, Light RW (1993). "The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia". Chest. 104 (5): 1486–9. PMID 8222812. Unknown parameter
|month=ignored (help) - ↑ Azoulay E, Fartoukh M, Similowski T, Galliot R, Soufir L, Le Gall JR; et al. (2001). "Routine exploratory thoracentesis in ICU patients with pleural effusions: results of a French questionnaire study". J Crit Care. 16 (3): 98–101. doi:10.1053/jcrc.2001.28784. PMID 11689765.
- ↑ 4.0 4.1 Ferreiro L, San José E, Valdés L (2014). "Tuberculous pleural effusion". Arch Bronconeumol. 50 (10): 435–43. doi:10.1016/j.arbres.2013.07.006. PMID 24721286.